Molecular Indicators of Systematic Fitness
Part of paid clinical trials in New Haven, Connecticut.
- Sponsor
- VO Health, Inc.
- Study ID
- NCT07393841
- Status
- Recruiting
Conditions
- Aging
- Athlete
- Exercise Physiology
- Fitness Testing
- Healthy Adult
- Human Performance
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- There is no intervention. — OTHERThe investigators are not administering an intervention for this study. To opportunistically capture prospective data, the investigators give participants the option for re-testing after a period of time where participants are undergoing a self-directed intervention (i.e., no influence of the research staff), such as training for a marathon or other fitness event.
Study Details
The goal of this study is to characterize associations between cardiorespiratory fitness, as measured by VO₂max/VO₂peak, and blood-based molecular measurements in adults. This is an observational study where research staff measures VO₂max/VO₂peak and collects fasted, resting blood samples on the same day. The main questions it aims to answer are: 1. Can a multi-analyte blood panel accurately predict directly measured VO₂max/VO₂peak? 2. How do these blood-based features vary across age, sex, and self-reported or documented physical activity profiles? 3. Are the predictor analytes able to capture changes in VO₂max/VO₂peak caused by a self-directed intervention (e.g., training for a marathon)? 4. What is the analytic reliability of the predictor biomarkers?
Key Dates
- Start date
- Jan 5, 2026
- Status verified
- Feb 2026
- Primary completion
- Jan 5, 2028
- Completion
- May 10, 2028
Study Design
- Enrollment
- 250 participants (estimated)
Primary Outcome Measure
A multi-analyte biomarker panel to predict maximal aerobic capacity [ Time Frame: Day 1 ]
Central Contacts
- Brooks P Leitner, MD, PhD443-474-7206
- Sean P Langan, PhD
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| VO Health, Inc. | New Haven | Connecticut | 06510 | Sean P Langan, PhD Brooks P Leitner, MD, PhD (PRINCIPAL_INVESTIGATOR) Sean P Langan, PhD (SUB_INVESTIGATOR) |
Find similar trials in New Haven, CT
Related Studies
- The Mito-Frail Trial: Effects of MitoQ on Vasodilation, Mobility and Cognitive Performance in Frail Older AdultsPHASE2 · Recruiting · UConn Health · Farmington, Connecticut
- Targeting Aging With a Ketone Ester for Function in FrailtyRecruiting · Buck Institute for Research on Aging · Novato, California
- Annual Wellness Visits vs GRACE-augmented Annual Wellness Visits For Older Adults With High Needs - Phase 2Recruiting · Massachusetts General Hospital · Derby, Connecticut
- Cognitive RemediationRecruiting · Cutter Lindbergh · Farmington, Connecticut